HEALTH● LOWAug 27 · Aug 27, 2026, 6:33 AM
AbbVie files for EMA approval of Skyrizi for Crohn’s disease treatment
Seeking Alpha Tech
AbbVie has submitted an application to the European Medicines Agency for approval of Skyrizi as a treatment for Crohn's disease. This step is part of the regulatory process for new pharmaceutical products.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Health
HEALTH53m agoUganda says no active Ebola cases after Nigeria confirms infectionPremium TimesHEALTH1h agoChristina Applegate does not have MS after all, 'I'm back to square one'NOS BuitenlandHEALTH1h agoIntermittent fasting: what a new study says about its effect on weight lossClarínHEALTH2h agoNigerian breaks global barrier, takes over world cancer control bodyVanguard Nigeria